Open access
Open access
Powered by Google Translator Translator

Critical Care & Emergencies (all articles)

Covid-19: More data on the increased risks to pregnant women and their newborn infants

23 Apr, 2021 | 08:44h | UTC

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study – JAMA Pediatrics

Editorial: COVID-19 in Pregnant Women and Their Newborn Infants

Commentaries: Pregnant women with COVID-19 face high mortality rate – University of Washington School of Medicine AND Covid-19 raises risks for expectant mothers and babies, study says – CNN

Related: Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis

 

Commentary on Twitter

 


Perioperative hemodynamic optimization: from guidelines to implementation—an experts’ opinion paper

23 Apr, 2021 | 08:21h | UTC

Perioperative hemodynamic optimization: from guidelines to implementation—an experts’ opinion paper – Annals of Intensive Care

 


New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis

23 Apr, 2021 | 08:06h | UTC

New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis – Journal of Clinical Medicine

 


An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria

23 Apr, 2021 | 08:05h | UTC

An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria – Journal of Clinical Medicine

 


Review: Oral Antiplatelet Therapy After Acute Coronary Syndrome

22 Apr, 2021 | 08:22h | UTC

Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review – JAMA (free for a limited period)

Audio Clinical Review: Dual Antiplatelet Therapy After Acute Coronary Syndrome – JAMA

 


Systematic review: Venoarterial Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism-Related Cardiac Arrest

22 Apr, 2021 | 08:18h | UTC

Venoarterial Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism-Related Cardiac Arrest: A Systematic Review – Critical Care Medicine

Summary: VA ECMO for Massive PE + Cardiac Arrest – Journal Feed

 


ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine Induced Immune Thrombotic Thrombocytopenia

21 Apr, 2021 | 07:11h | UTC

ISTH Interim Guidance for the Diagnosis and Treatment on VaccineInduced Immune Thrombotic Thrombocytopenia (Updated 20 April, 2021) – International Society on Thrombosis and Haemostasis

See also: Diagnostic Flow Chart

 

Commentary on Twitter

 


Systematic review: Thrombolytic therapy for acute massive or submassive pulmonary embolism

21 Apr, 2021 | 06:20h | UTC

Thrombolytic therapy for pulmonary embolism – Cochrane Library

Summary: Drugs to dissolve pulmonary embolism (blood clot in the lungs) – Cochrane Library

 


Review: Dosing Fluids in Early Septic Shock

21 Apr, 2021 | 06:19h | UTC

Dosing Fluids in Early Septic Shock – CHEST

 


COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

21 Apr, 2021 | 07:07h | UTC

COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets – European Medicines Agency

Commentary: Johnson & Johnson vaccine: EU regulator says blood clot very rare side effect – BBC

 

Commentary on Twitter

 


Vaccine-induced Immune Thrombotic Thrombocytopenia: Frequently Asked Questions

21 Apr, 2021 | 07:09h | UTC

Vaccine-induced Immune Thrombotic Thrombocytopenia: Frequently Asked Questions – American Society of Hematology

 


M-A: Corticosteroids in COVID-19 and non-COVID-19 ARDS

20 Apr, 2021 | 06:11h | UTC

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis – Intensive Care Medicine

 


Guideline Synopsis: Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation

21 Apr, 2021 | 06:41h | UTC

Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation – JAMA (free for a limited period)

Original guideline: #ESCCongress – 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation AND Summary: The ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation – European Heart Journal

 


Outcome of acute kidney injury: how to make a difference?

20 Apr, 2021 | 05:26h | UTC

Outcome of acute kidney injury: how to make a difference? – Annals of Intensive Care

 


RCT: No benefit from second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis

18 Apr, 2021 | 21:21h | UTC

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial – The Lancet Neurology (link to abstract – $ for full-text)

 


Study Commentary | What if the EHR Age-Adjusts D-dimer for You?

18 Apr, 2021 | 21:04h | UTC

What if the EHR Age-Adjusts D-dimer for You? – Journal Feed

Original study: Multi-center implementation of automated age-adjusted D-dimer results reduces unnecessary PE imaging – The American Journal of Emergency Medicine (link to abstract – $ for full-text)

 


Hemodialysis Emergencies: Core Curriculum 2021

16 Apr, 2021 | 06:13h | UTC

Hemodialysis Emergencies: Core Curriculum 2021 – American Journal of Kidney Diseases

 

Commentary on Twitter

 


Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials

16 Apr, 2021 | 06:14h | UTC

Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials – Advances in Therapy

 


Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months

16 Apr, 2021 | 06:35h | UTC

Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months – Intensive Care Medicine

 

Commentary on Twitter

 


M-A: Treatment with hydroxychloroquine is associated with increased mortality in COVID-19 patients

16 Apr, 2021 | 06:30h | UTC

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials – Nature Communications

 

Commentaries on Twitter

 


Perspective | Ivermectin is the new Hydroxychorloquine

16 Apr, 2021 | 06:28h | UTC

Ivermectin is the new Hydroxychorloquine – Science-Based Medicine

 


Were pregnant women more affected by COVID-19 in the second wave of the pandemic?

16 Apr, 2021 | 06:24h | UTC

Were pregnant women more affected by COVID-19 in the second wave of the pandemic? – The Lancet

Related: Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis

 


Pandemic Boosts an Old Idea—Bringing Acute Care to the Patient

15 Apr, 2021 | 06:51h | UTC

Pandemic Boosts an Old Idea—Bringing Acute Care to the Patient – JAMA

Related studies: Cohort Study: Selected patients with Covid-19 can be safely discharged on home oxygen, with low mortality and readmission rates AND Association of a Bundled Hospital-at-Home and 30-Day Postacute Transitional Care Program With Clinical Outcomes and Patient Experiences – JAMA Internal Medicine

 


Case Report: Thrombotic Thrombocytopenia after Johnson & Johnson Vaccine

15 Apr, 2021 | 07:02h | UTC

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination – New England Journal of Medicine

Related: U.S. regulators pause Johnson & Johnson vaccine rollout over rare (1 in a million) cases of blood clots AND 4 Things to Know About the J&J Covid Vaccine Pause – Kaiser Health News AND Why Johnson & Johnson shots were paused — and why that’s so confusing – Vox AND Is it the adenovirus vaccine technology, used by AstraZeneca and Johnson & Johnson, causing blood clots? There’s no evidence yet – The Conversation

 


New studies suggest SARS-CoV-2 variant B.1.1.7 is not more deadly, just more transmissible

14 Apr, 2021 | 02:12h | UTC

Study 1: Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study – The Lancet Public Health

Study 2: Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study – The Lancet Infectious Diseases

Commentaries: Expert reaction to two papers looking at the transmissibility and severity of the B.1.1.7 variant – Science Media Centre AND UK coronavirus variant not more deadly, just spreads more easily, studies find – LiveScience

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.